Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:14 PM
Ignite Modification Date:
2025-12-24 @ 9:14 PM
NCT ID:
NCT00266604
Eligibility Criteria:
Inclusion Criteria:
* Patients having new-onset epilepsy or epilepsy relapse characterized by partial-onset seizures or primary generalized tonic-clonic seizures
* having at least 1 seizure within the 3 months prior to entry
* who are previously untreated for epilepsy, previously treated for epilepsy, or if currently taking epilepsy medication, must have been taking it for less than 6 weeks
* weighing at least 25 kilograms (approximately 55 pounds)
* if female of childbearing potential, must be using an acceptable method of birth control
Exclusion Criteria:
* Patients who have previously taken topiramate for the treatment of epilepsy
* who are currently taking topiramate for any reason
* having active liver disease
* having a clinically significant medical condition or disease
* women who are pregnant or breastfeeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
10 Years
Study:
NCT00266604
Study Brief:
Protocol Section:
NCT00266604